ARS Pharmaceuticals Chief Commercial Officer Margaret Ekins Smith files initial beneficial ownership statement
SPRY•Initial Form 3 filing
- ARS Pharmaceuticals Chief Commercial Officer Margaret Ekins Smith filed an initial Form 3 on Aug. 17, 2026.
SPRY•